---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-001100"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-01-24T23:59:59+00:00"
generated_at: "2026-06-20T10:40:27.589063+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Heart Test Labs amends loan; extends FRV note to Sep 2024, reduces 2023 debt payments by $1.2M

## Summary
- Amendment No. 4 to Loan and Security Agreement dated Jan 24, 2023 with lenders FRV and John Q. Adams.
- FRV note (original $500k) maturity extended to Sept 30, 2024; all principal and accrued interest due then.
- JQA note (original $500k): accrued interest from June 28, 2022 due Sept 30, 2023; principal and later interest due March 31, 2024.
- Company states amendment reduces 2023 debt and accrued interest repayment obligations by $1.2 million.
- Company also releases all claims against lenders under the agreement.

## SEC filing metadata
- accession: 0000950170-23-001100
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-01-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023001100/0000950170-23-001100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023001100/hscs-20230124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-001100
- JSON: https://secwatch.observer/filing/0000950170-23-001100.json
- Plain text: https://secwatch.observer/filing/0000950170-23-001100.txt

## Key facts
- Material Agreements
  HeartSciences Inc. amended Amendment No. 4 with Front Range Ventures LLC and John Q. Adams valued at $1.2 million (effective 2023-01-24).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Front Range Ventures LLC and John Q. Adams
  - Value: $1.2 million
  - Effective: 2023-01-24
  source text: On January 24, 2023, Heart Test Laboratories, Inc. (the “Company”) entered into Amendment No. 4 (the “Amendment”) to the Loan and Security Agreement dated April 24, 2020 (the “Agreement”) by and among the Company, Front Range Ventures LLC (“FRV”) and John Q. Adams (“Adams”) which was previously amended on September 30, 2021, November 3, 2021 and May 24, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023001100/0000950170-23-001100-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.